openPR Logo
Press release

Typhoid Vaccines Market to Record an Exponential CAGR by 2025

06-08-2018 07:30 PM CET | Health & Medicine

Press release from: Transparency Market Research

Typhoid Vaccines Market to Record an Exponential CAGR by 2025

Typhoid is a bacterial infection that can lead to diarrhea, high fever, and vomiting. It can be fatal if not treated properly. It is caused by the bacterium Salmonella typhi. The disease is more prevalent in low-income countries, as basic prevention strategies such as good hygiene practices and access to clean water are not available in these countries. However, the spread of the disease in low-income countries is preventable. Every year, around 5,700 cases are reported only in the U.S., out of which 75% occur while traveling overseas. Globally, around 21.5 million people contract typhoid every year. Typhoid can be treated with antibiotics. However, vaccination is more effective for eradicating typhoid, as typhoid vaccines is beneficial in two ways, one by providing protection to vaccinated individual and two, by providing herd immunity indirectly to unvaccinated individuals when the vaccination is carried out on a large scale.

The global Typhoid Vaccines Market can be segmented in terms of product, mode of administration, distribution channel, and end-user. In terms of product, typhoid vaccines are of four types viz. Ty21a, Vi capsular polysaccharide vaccine, Vi Conjugate (Vi-TT), and Vi Conjugate (Vi-REPA). Ty21a is a live vaccine and Vi capsular polysaccharide is a sub-unit vaccine. The other two types are restricted to the private sector and they do not have global acceptance. For instance, Vi Conjugate (Vi-TT) is licensed only for the market in India. Based on mode of administration, the typhoid vaccines market can be segmented into oral or injectable.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37556

For instance, Ty21a is taken orally, while Vi capsular polysaccharide vaccine is injectable. Based on distribution channel, the typhoid vaccines market can be classified into hospitals, pharmacies, and clinics / health care centers associated with government programs. The inflow of patients to hospitals is expected to increase during the forecast period, as hospitals are considered to be more reliable and they have a large number of suppliers, reimbursement authority, and government support. Based on end-user, the typhoid vaccines market has been segmented into pediatrics and adults.

The typhoid vaccines market is driven by several factors such as increasing government initiatives, rising prevalence of typhoid, growing immunization campaigns across the globe, rising initiatives by non-government organizations for vaccination, and increasing investments by companies in vaccine development. Increased research on typhoid vaccine in the emerging market have opened an array of growth opportunities for the typhoid vaccines market. However, less availability of typhoid vaccines in remote areas and strict regulatory measures are expected to restrain the market from 2017 to 2025.

Based on geography, the global typhoid vaccines market has been divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the major share of the typhoid vaccines market in terms of revenue in 2016. This is attributable to increasing awareness among people in the region, which leads to the rise in demand for vaccination to infants, children, and adults. Also, easy availability of vaccines in the U.S. and favorable government initiatives for vaccination programs fuel the typhoid vaccines market in the region. The market for typhoid vaccines in Asia Pacific is expected to expand at the maximum CAGR during the forecast period, due to government initiatives for immunization against typhoid and large population base, especially in China and India.

China is likely to lead the Asia Pacific typhoid vaccines market during the forecast period, owing to increase in government support for vaccination and rise in the number of people with typhoid disease in the region. Brazil is likely to be a prominent market for typhoid vaccines in Latin America by 2025. The developing health care infrastructure and interest of key players in investing in Brazil by establishing manufacturing units in the region are major factors driving the typhoid vaccines market in Brazil. GCC dominates the typhoid vaccines market in the Middle East, whereas, South Africa holds the leading share of the market in Africa. The typhoid vaccines market in Africa is experiencing strong growth, due to rapid rise in vaccination programs, frequent typhoid outbreaks in the region, and increasing investments by major players.

Key players operating in the global typhoid vaccines market include AstraZeneca, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer, Inc., Sanofi, and Johnson & Johnson.

View Report -

https://www.transparencymarketresearch.com/typhoid-vaccines-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Typhoid Vaccines Market to Record an Exponential CAGR by 2025 here

News-ID: 1076294 • Views:

More Releases from Transparency Market Research

Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:
Augmented Industrial Reality Market - Global Industry Analysis, Size, Share, Gro …
Augmented Industrial Reality (AR) is rapidly transforming the landscape of industrial operations worldwide. With a staggering 28.4% Compound Annual Growth Rate (CAGR) projected from 2023 to 2031, the market is poised to reach a valuation of US$ 25.7 billion by the end of 2031, up from US$ 2.7 billion in 2022. Analysts attribute this exponential growth to the technology's ability to seamlessly integrate digital elements with physical production lines, thereby
Global Engineering R&D Services Outsourcing Market Set to Surge, Projected to Re …
The Engineering R&D Services Outsourcing Market has experienced significant growth in recent years, driven by factors such as digital transformation across various industry verticals and an increasing demand for access to a global talent pool and advanced technologies. In 2022, the global industry was valued at US$ 148.0 billion, and it is expected to reach US$ 400.0 billion by the end of 2031, with a projected CAGR of 11.8% from
Building Energy Simulation Software Market: Transforming the Future of Sustainab …
The Building Energy Simulation Software Market is poised for significant growth, driven by the escalating demand for energy-efficient building solutions worldwide. Valued at US$ 4.4 billion in 2022, the market is projected to surge at a robust CAGR of 10.7% from 2023 to 2031, reaching an estimated worth of US$ 10.8 billion by the end of 2031. This remarkable expansion is attributed to the increasing adoption of IoT and smart

All 5 Releases


More Releases for Typhoid

Continual Inventions To Accelerate The Typhoid Antibody Testing Market
The Typhoid Antibody Testing Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well,
Typhoid Vaccine Market is Thriving Worldwide with Top Companies like: Merck, Gla …
Los Angeles, United State, –The report titled Global Typhoid Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Typhoid Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global
Typhoid Treatment Market Intelligence Report Offers Growth Prospects
Typhoid is contagious disease caused by bacterial species, salmonella enterica and serovar typhi. It is also caused by salmonella paratyphi. A person is infected with typhoid on ingestion of water or food contaminated with stools of an individual infected with typhoid. Typhoid is also referred as typhoid fever, enteric fever, gastric fever, infantile remittent fever, abdominal typhus, nervous fever, and slow fever. Common symptoms of typhoid include, loss of appetite,
Typhoid Vaccines Market Size, Future Prospects & Competitive Analysis, through 2 …
Typhoid is a bacterial infection that can lead to diarrhea, high fever, and vomiting. It can be fatal if not treated properly. It is caused by the bacterium Salmonella typhi. The disease is more prevalent in low-income countries, as basic prevention strategies such as good hygiene practices and access to clean water are not available in these countries. However, the spread of the disease in low-income countries is preventable. Every
Typhoid Fever Pharmaceutical and Healthcare Pipeline Review H2, 2017
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Typhoid Fever - Pipeline Review, H2 2017” to its report offerings. The report provides comprehensive information on the therapeutics under development for Typhoid Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246549 Typhoid fever is an infection that causes
Global Typhoid Vaccine Market Research Report 2017
Report Hive Market Research Released a New Research Report of 163 pages on Title " Global Typhoid Vaccine Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Typhoid antibodies are immunizations that counteract typhoid fever. There are two sorts that are generally accessible: Ty21a (a live antibody given by mouth) and Vi capsular polysaccharide immunization (an injectable subunit antibody). They are around 30 to 70% compelling for amid the initial